Torque3 is developing a neurorehabilitation solution that has shown in early testing to result in significantly better recovery outcomes.
A wealth of research over the last 30 years has strongly indicated that stroke recovery can be significantly improved through immersive stimulation and robotic assistance.
The Torque3 system leverages this research with an approach of uncompromising design and implementation combining a robotic chair and virtual reality.
In this episode, Founder/CEO David Ellzey shares some of the science behind Torque3 and insights into where they are headed.
Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent mucosal infections with a focus on improving the quality of...
Julie Anderson is the Director of Strategic Initiatives at Cambia Grove and a healthcare veteran.Cambia Grove is a health care innovation hub focused on...
Eyetamins is a healthcare technology and life sciences company focused on therapeutics and consumer innovations in the $200B eye health and wellness space. They...
